Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of Cavitation From DEFINITY and DEFINITY RT.

Ultrasound in medicine & biology·2026
Same author

HFpEF risk assessment using H<sub>2</sub>FPEF score in community-dwelling young Hispanic adults.

Frontiers in cardiovascular medicine·2026
Same author

Associations Between Metabolic Dysregulation and Stage B Heart Failure in Hispanic Populations.

Echocardiography (Mount Kisco, N.Y.)·2026
Same author

Nuclear receptor subfamily 4 group a member 2 induces a Warburg-like effect and promotes phospholipids synthesis in the mouse heart.

Physiological genomics·2026
Same author

A novel workflow for developing 3D mitral valve-left ventricular model using 3D-Transesophageal echocardiography.

Computers in biology and medicine·2025
Same author

Reply to the Letter to the Editor in response to: "Acoustic Droplet Vaporization Efficiency and Oxygen Scavenging in Whole Blood".

Ultrasound in medicine & biology·2025

Related Experiment Video

Updated: Jun 14, 2026

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

ECHOGENIC LIPSOMES FOR TARGETED DRUG DELIVERY.

Christy K Holland1, David D McPherson

  • 1Department of Biomedical Engineering, University of Cincinnati, 231 Albert Sabin Way, Medical Sciences Building, Room 6167, Cincinnati, OH, 45267-0586, USA.

Proceedings. IEEE International Symposium on Biomedical Imaging
|April 13, 2010
PubMed
Summary

Echogenic immunoliposomes (ELIP) facilitate ultrasound-controlled drug delivery. Research shows stable cavitation enhances thrombolysis but requires optimized strategies to avoid bioeffects.

More Related Videos

Targeting Drugs to Larval Zebrafish Macrophages by Injecting Drug-Loaded Liposomes
11:31

Targeting Drugs to Larval Zebrafish Macrophages by Injecting Drug-Loaded Liposomes

Published on: February 18, 2020

Solid Lipid Nanoparticles (SLNs) for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles (SLNs) for Intracellular Targeting Applications

Published on: November 17, 2015

Related Experiment Videos

Last Updated: Jun 14, 2026

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

Targeting Drugs to Larval Zebrafish Macrophages by Injecting Drug-Loaded Liposomes
11:31

Targeting Drugs to Larval Zebrafish Macrophages by Injecting Drug-Loaded Liposomes

Published on: February 18, 2020

Solid Lipid Nanoparticles (SLNs) for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles (SLNs) for Intracellular Targeting Applications

Published on: November 17, 2015

Area of Science:

  • Biomedical Engineering
  • Ultrasound Technology
  • Drug Delivery Systems

Background:

  • Echogenic immunoliposomes (ELIP) are being developed for ultrasound-guided drug delivery.
  • In vitro studies link stable cavitation to enhanced recombinant tissue Plasminogen Activator (rt-PA) mediated thrombolysis.
  • Optimizing cavitation and mitigating bioeffects remain key challenges.

Purpose of the Study:

  • To review in vitro sonothrombolysis studies using echogenic liposomes and rt-PA.
  • To discuss strategies for developing ultrasound-enhanced thrombolysis.
  • To explore methods for optimizing ultrasound-controlled drug delivery.

Main Methods:

  • Review of in vitro sonothrombolysis studies.
  • Analysis of studies using commercial ultrasound contrast agents or echogenic liposomes with rt-PA.
  • Discussion of cavitation nucleation and bubble activity.

Main Results:

  • Stable cavitation, characterized by gentle bubble pulsation, correlates with improved rt-PA thrombolysis.
  • Echogenic liposomes can nucleate stable cavitation for enhanced thrombolysis.
  • Strategies for optimization and bioeffect mitigation are under investigation.

Conclusions:

  • Ultrasound-controlled drug delivery using ELIP shows promise for thrombolysis.
  • Further research is needed to optimize stable cavitation and ensure safety.
  • Development of effective ultrasound-enhanced thrombolysis strategies is ongoing.